More Than Half of COVID - 19 Survivors Have Postacute  Sequelae

Most common sequelae include functional mobility impairments, pulmonary abnormalities, and mental health disorders
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Cardiology, Dermatology, Family Medicine, Gastroenterology, Infections, Internal Medicine, Neurology, ENT, Psychiatry, Pulmonology, Anesthesiology & amp; Pain, Journal, Source Type: news

Related Links:

ConclusionThe effects of the COVID-19 pandemic on patients with chronic pain were not apparent in the short-term.Clinical trail registration: UMIN000043174
Source: Journal of Anesthesia - Category: Anesthesiology Source Type: research
CONCLUSIONS: Given the perceived benefits of regional over general anesthesia, approximately half of the members of three regional anesthesia societies seem to have expanded their use of regional anesthesia techniques during the initial surge of the COVID-19 pandemic.PMID:34796460 | PMC:PMC8601752 | DOI:10.1007/s12630-021-02150-8
Source: Canadian Journal of Anaesthesia - Category: Anesthesiology Authors: Source Type: research
CONCLUSION: An AMT assembled during the COVID-19 pandemic showed high competency and effectiveness, and had favourable impact on the main responsible physicians who activated the team.PMID:34761327 | DOI:10.1007/s12630-021-02144-6
Source: Pain Physician - Category: Anesthesiology Authors: Source Type: research
Post-acute coronavirus disease 2019 (COVID-19) syndrome is a novel, poorly understood clinical entity with life-impacting ramifications. Patients with this syndrome, also known as “COVID-19 long-haulers,” often present with non-specific ailments involving more than one body system. The most common complaints include dyspnea, fatigue, brain fog, and chest pain. There is currently no single agreed-upon definition for post-acute COVID-19 syndrome, but most agree that criteri on for this syndrome is the persistence of mental and physical health consequences after initial infection.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Source Type: research
Chronic pain is a nonnegligible challenge, given its considerable social and economic burden and its significant contribution to the opioid crisis, thus shedding light on the need for adequate nonopioid treatment options. Treatment of chronic pain in the COVID-19 pandemic is challenging for pain physicians in terms of risks of harm from both undertreatment and inappropriate treatment. This presentation highlights the most novel evidence-based approaches to chronic pain and focuses on practical treatment considerations in light of COVID-19.
Source: Journal of the American Academy of Child and Adolescent Psychiatry - Category: Psychiatry Authors: Tags: Clinical Perspectives 55 Source Type: research
AbstractObjectivesWe aim to study the effect of epidural morphine as a means to reduce high respiratory drive in COVID 19 patients on non-invasive ventilation (NIV) —primary end point—and to study its effect on respiratory parameters, subjective patient comfort, rates of endotracheal intubation, duration of mechanical ventilation and mortality.Trial designParallel group, randomised, double blind, single centre placebo control trial. Allocation ratio 1:1, superiority trialParticipantsTrial site and population —COVID ICU patients in the All India Institute of Medical Sciences (AIIMS) Bhubaneswar, Odisha, In...
Source: Trials - Category: Research Source Type: clinical trials
Best Pract Res Clin Anaesthesiol. 2021 Oct;35(3):307-319. doi: 10.1016/j.bpa.2020.11.005. Epub 2020 Nov 16.ABSTRACTTelemedicine is the medical practice of caring for and treating patients remotely. With the spread of the coronavirus disease-2019 (COVID-19) pandemic, telemedicine has become increasingly prevalent. Although telemedicine was already in practice before the 2020 pandemic, the internet, smartphones, computers, and video-conferencing tools have made telemedicine easily accessible and available to almost everyone. However, there are also new challenges that health care providers may not be prepared for, including ...
Source: Pain Physician - Category: Anesthesiology Authors: Source Type: research
This article provides an update of recent practice trends in neuraxial labor analgesia. It reviews available evidence regarding management of labor pain in obstetric patients with COVID-19, serious adverse events in obstetric anesthesia to help inform risk/benefit decisions, and increasingly popular neuraxial labor analgesia techniques and adjuvants. State-of-the-art modes of epidural drug delivery are also discussed.Recent FindingsThere has recently been a focus on several considerations specific to obstetric anesthesia, such as anesthetic management of obstetric patients with COVID-19, platelet thresholds for the safe pe...
Source: Current Anesthesiology Reports - Category: Anesthesiology Source Type: research
ConclusionThe effects of the COVID-19 pandemic on patients with chronic pain were not apparent in the short-term.Clinical trail registration: UMIN000043174
Source: Journal of Anesthesia - Category: Anesthesiology Source Type: research
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) ev...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
More News: Anesthesia | Anesthesiology | Brain | Cardiology | COVID-19 | Dermatology | Gastroenterology | Heart | Internal Medicine | Men | Neurology | Pain | Psychiatry | Respiratory Medicine | Skin